Stefan Weber

Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden.

Dipylon Medical AB engages in the research and development of pharmaceutical products. The firm manufactures and sells products, materials and general medical instruments. It offers metabolic patient monitoring system. The company was founded on April 3, 1984 and is headquartered in Solna, Sweden.

McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY.

Investor Growth Capital AB (IGC) is a venture capital subsidiary of Investor AB founded in 1968. The firm is headquartered Stockholm, Sweden.

Cellectricon AB provides cell-based screening services to accelerate drug discovery. The firm develops and validates exciting central nervous system and peripheral pain assays using primary cells, accelerating the path from assay validation to compound screening. Its system is equipped with an imaging-based microplate reader to simultaneously record transient fluorescence and luminescence signals, providing real-time monitoring and readouts of cell culture response. The company was founded by Jan Owe Owesson Orwar, Daniel T. Chiu and Stig Anders Jakob Lindberg in 1999 and is headquartered in Molndal, Sweden.

Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden.

Amic AB develops in vitro diagnostic technologies for use in point-of-care diagnostic tests. Its technology uses a molded plastic device 4castchip & a optical detection system for precise and sensitive quantification of immunoassays. The company was founded in 1998 by Ove Öhman and is headquartered in Uppsala, Sweden

Part of Alligator Bioscience AB, Atlas Therapeutics AB develops and manufactures antibody drugs. The company is based in Stockholm, Sweden. Atlas Therapeutics was acquired by Alligator Bioscience AB on October 18, 2013.

Part of MiCo IVD Holdings, LLC, Fiomi Diagnostics AB is a Swedish company that develops, manufactures, and markets diagnostic test kits. The company is based in Uppsala, Sweden. Fiomi Diagnostics was acquired by Trinity Biotech Plc on March 01, 2012 for $13.12 million.

Ginolis AB develops components in polymer by first producing the parts in original through different methods for sculpting silicon and glass wafers. These originals are transferred to molds in which the final components are manufactured through time-effective and thus economical favorable polymer replication processes. The polymers themselves, compared with silicon micromechanics, could also add material property advantages with the vast variety of materials available. They can with this platform serve many different fields all with the same need of precision and complexity. Ginolis AB has the skill and experience to integrate different functions onto the very same chip in order to achieve functions that, if they are at all possible to manufacture with traditional technique, needs several parts assembled to mechanical systems with higher cost for the parts as a consequence. These functions include nano- and microfludic channels, surface chemistry, electrical wave guides and connectors, refractive and diffractive micro-optics.

Part of Getinge AB, Eirus Medical AB is a Swedish company that provides medical technology development services. The company is based in Solna, Sweden. Eirus Medical was acquired by Getinge AB from Dipylon Medical AB on June 30, 2012 for $0.72 million.

Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden.

Amylon Therapeutics BV is a biopharmaceutical company, which engages in the research and development of therapies for the central nervous system. It specializes in ribonucleic acid modulation technology to target rare genetic disorders. The company was founded by Thomas de Vlaam and is headquartered in Leiden, the Netherlands.

Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna.

Part of Pfizer Inc., Pfizer ApS is a Danish bio-pharmaceutical company. The company is based in Ballerup, Denmark. Pfizer is one of the world's leading bio-pharmaceutical companies.

Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto.

Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.

2941881 Canada, Inc. manufactures and supplies pelvic health and gastrointestinal equipment and consumables. The company was founded by Raymond George Yves Laborie in 1967 and is headquartered in Mississauga, Canada.

Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark.

Luigi Lavazza SpA manufactures and distributes coffee. Its products include coffee capsules; instant coffee; compatible capsules; and coffee blends, beans, and pods. It also offers accessories including espresso cups and spoons, mugs, capsule holder, sweet bites, frothers, coffee maker, and descaling. The company was founded by Luigi Lavazza in 1895 and is headquartered in Turin, Italy.

Ducati Motor Holding SpA engages in the design and manufacture of motorcycles. The firm also offers motorcycle accessories such as chassis and brake systems, electric and electronic components exhaust systems, fiberglass and plastic fibers, garage accessories, and specialty materials. The company was founded by Adriano Ducati and Marcello Ducati in 1926 and is headquartered in Bologna, Italy.

DOC Generici Srl manufactures and distributes generic drugs. The firm offers medicines for the treatment of chronic diseases such as cardiovascular and neurological. The company was founded in 1996 and is headquartered in Milan, Italy.

Axxam SpA provides pharmaceuticals services. The firm specializes in molecular biology, electrophysiology, cellular and biochemical systems. The company was founded by Stefan Lohmer and Alessandro Sidoli in November 2001 and is headquartered in Bresso, Italy.